Argenx
ARGX
#528
Rank
NZ$68.59 B
Marketcap
$1,139
Share price
1.07%
Change (1 day)
91.17%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

We have found no dividend yield history for this company